Biomarkers and diagnosis of Heart Failure

Name: Biomarkers and diagnosis of Heart Failure
Rating: 4.3 (52 reviews)

The role of biomarkers in diagnosis and prognosis of Heart Failure

Created byGiorgio Ferrari

Last updated 12/2018

English

What you'll learn

My students will learn how to read biomarkers levels to improve diagnosis and prognosis prediction for patients with Heart Failure

Course content

1 section • 5 lectures • 38m total length

Introduction to Heart Failure diagnosis problems7:35
Natriuretic Peptides for Heart Failure Diagnosis8:34
Natriuretic Peptides for Heart Failure Prognosis7:26
Explore the prognostic value of BNP and NT-proBNP in acute and chronic heart failure, linking levels to mortality and hospitalization, and monitoring therapy with attention to CKD and obesity.
The role of ANP4:22
ANP is a stable biomarker alongside BNP for heart failure; combining ANP with BNP via a multi-marker approach enhances diagnostic accuracy, especially in the grey zone and in obesity.
Beyond Natriuretic Peptides10:11

Requirements

This course is dedicated to people with a background knowledge in medicine and health related topics

Description

This course aims to provide a specialized overview on the use of biomarkers in the diagnosis and prognosis of heart failure (HF). The use of biomarkers is now essential for a correct diagnosis of heart failure, to establish a forecast of prognosis and also to guide the choice of the best possible therapy. This course analyzes the biochemical bases and cutoff levels for the main biological markers used in clinical practice in the setting of patients with heart failure or suspected heart failure based on the clinical picture.

Who this course is for:

Ideally Medical Students, Medical doctors, Health professionals (nurses, paramedics, etc) and all interested in Health topics particularly in cardiology